Tsumura is a pharmaceutical company primarily engaged in the manufacture and sale of ethical pharmaceutical and over-the counter drugs. Co.'s principal products include Kampo (Japanese traditional herbal medicines), such as "Daikenchuto," "Hochuekkito," "Saireito," "Kamishoyosan," "Goshajinkigan," "Bakumondoto," "Shakuyakukanzoto," "Shoseiryuto," "Kakkonto" and others; as well as bath additives , such as "Bath Herb." In addition, Co., through its subsidiaries, is engaged in the operation of pharmacies, the provision of transportation services and the development of medicine in the U.S.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.